SE435291B - Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra - Google Patents

Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra

Info

Publication number
SE435291B
SE435291B SE7610722A SE7610722A SE435291B SE 435291 B SE435291 B SE 435291B SE 7610722 A SE7610722 A SE 7610722A SE 7610722 A SE7610722 A SE 7610722A SE 435291 B SE435291 B SE 435291B
Authority
SE
Sweden
Prior art keywords
yltiomethyl
sulfaminoethyl
cefem
tetrazol
acylamino
Prior art date
Application number
SE7610722A
Other languages
English (en)
Swedish (sv)
Other versions
SE7610722L (sv
Inventor
D A Berges
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/704,142 external-priority patent/US4118491A/en
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of SE7610722L publication Critical patent/SE7610722L/xx
Publication of SE435291B publication Critical patent/SE435291B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7610722A 1975-10-30 1976-09-28 Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra SE435291B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62716475A 1975-10-30 1975-10-30
US66583776A 1976-03-11 1976-03-11
US05/704,142 US4118491A (en) 1976-03-11 1976-07-12 7-Acyl-3-(sulfaminoalkyl substituted tetrazolylthiomethyl)cephalosporins, antibacterial compositions containing them and methods of treating bacterial infections with them

Publications (2)

Publication Number Publication Date
SE7610722L SE7610722L (sv) 1977-05-01
SE435291B true SE435291B (sv) 1984-09-17

Family

ID=27417417

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7610722A SE435291B (sv) 1975-10-30 1976-09-28 Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
SE8006413A SE452621B (sv) 1975-10-30 1976-09-28 7-amino cefalosporinderivat till anvendning som mellanprodukt for framstellning av motsvarande 7-substituerade cefalosporinderivat
SE8006414A SE437025B (sv) 1975-10-30 1980-09-12 1-(2-sulfaminoetyl)-tetrazol-5-tiol till anvendning for framstellning av cefalosporinforeningar med antibakteriell aktivitet

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8006413A SE452621B (sv) 1975-10-30 1976-09-28 7-amino cefalosporinderivat till anvendning som mellanprodukt for framstellning av motsvarande 7-substituerade cefalosporinderivat
SE8006414A SE437025B (sv) 1975-10-30 1980-09-12 1-(2-sulfaminoetyl)-tetrazol-5-tiol till anvendning for framstellning av cefalosporinforeningar med antibakteriell aktivitet

Country Status (17)

Country Link
JP (1) JPS6053026B2 (enrdf_load_html_response)
AT (1) AT353957B (enrdf_load_html_response)
AU (1) AU505141B2 (enrdf_load_html_response)
CA (1) CA1071188A (enrdf_load_html_response)
CH (1) CH627757A5 (enrdf_load_html_response)
DE (1) DE2649545A1 (enrdf_load_html_response)
DK (1) DK463176A (enrdf_load_html_response)
ES (1) ES452769A1 (enrdf_load_html_response)
FI (1) FI60868C (enrdf_load_html_response)
FR (3) FR2361896A1 (enrdf_load_html_response)
GB (3) GB1570093A (enrdf_load_html_response)
GR (1) GR61667B (enrdf_load_html_response)
IE (1) IE44393B1 (enrdf_load_html_response)
IL (3) IL50546A (enrdf_load_html_response)
LU (1) LU76092A1 (enrdf_load_html_response)
NL (1) NL7612010A (enrdf_load_html_response)
SE (3) SE435291B (enrdf_load_html_response)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117123A (en) * 1977-06-09 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-(2-sulfamidoethyl)tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
AT383811B (de) * 1983-09-22 1987-08-25 Biochemie Gmbh Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
US4717531A (en) * 1983-09-23 1988-01-05 Westinghouse Electric Corp. Fuel transfer system upender using translation drive

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207752A1 (es) * 1973-03-30 1976-10-29 Fujisawa Pharmaceutical Co Procedimiento para obtener acidos 7-amino-sustituido-3-tiometilsustituido-3-cefem-4-carboxilicos
NL7414119A (nl) * 1973-10-31 1975-05-02 Fujisawa Pharmaceutical Co Werkwijze ter bereiding van 1h-tetrazool-5-thiol- derivaten en 1-gesubstitueerde 1h-tetrazool- -5-thiolen.
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
FI60868B (fi) 1981-12-31
CA1071188A (en) 1980-02-05
SE8006413L (sv) 1980-09-12
FR2361896A1 (fr) 1978-03-17
AU505141B2 (en) 1979-11-08
IE44393L (en) 1977-09-11
SE437025B (sv) 1985-02-04
IL56758A0 (en) 1979-05-31
AU1870276A (en) 1978-04-20
ATA807276A (de) 1979-05-15
GR61667B (en) 1978-12-05
ES452769A1 (es) 1978-01-16
JPS5257191A (en) 1977-05-11
FR2351982B1 (enrdf_load_html_response) 1981-07-03
NL7612010A (nl) 1977-05-03
GB1570094A (en) 1980-06-25
IL56757A0 (en) 1979-05-31
FR2337720B1 (enrdf_load_html_response) 1981-07-10
FR2337720A1 (fr) 1977-08-05
AT353957B (de) 1979-12-10
FI60868C (fi) 1982-04-13
DE2649545A1 (de) 1977-05-12
IL50546A (en) 1980-07-31
GB1570093A (en) 1980-06-25
JPS6053026B2 (ja) 1985-11-22
DK463176A (da) 1977-05-01
FI763044A7 (enrdf_load_html_response) 1977-05-01
SE452621B (sv) 1987-12-07
FR2361896B1 (enrdf_load_html_response) 1979-02-23
GB1570095A (en) 1980-06-25
SE7610722L (sv) 1977-05-01
IE44393B1 (en) 1981-11-18
LU76092A1 (enrdf_load_html_response) 1977-05-17
SE8006414L (sv) 1980-09-12
CH627757A5 (en) 1982-01-29
FR2351982A1 (fr) 1977-12-16
IL50546A0 (en) 1976-11-30

Similar Documents

Publication Publication Date Title
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE420199B (sv) Forfarande for framstellning av 16-oxiderade prostansyraderivat
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE436572B (sv) Forfarande for framstellning av androstadien-17-karbonsyraestrar
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
SE441360B (sv) Forfarande for framstellning av fosfonsyraderivat
SE434057B (sv) Forfarande for framstellning av nya rifamycinforeningar
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
BG26526A3 (bg) Метод за получаване на 1-(бензазолилалкил)пиперидинови производни
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE7802609L (sv) Forfarande for framstellning av 1-azaxanton-3-karboxylsyraderivat
SE416479B (sv) Forfarande for framstellning av hogrena alkolimetallhalogenidkristaller
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
NO141050C (no) Fremgangsmaate ved fremstilling av 5-fluor-2-methyl-1-(p-methylsulfinylbenzyliden)-ind-2-en-3-yl-eddiksyre
IT1068946B (it) Procedimento per prepararae triemtilidrochinone
NO821484L (no) Fremgangsmaate for fremstilling av fosfonsyrederivater
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE434157B (sv) Forfarande for framstellning av 6-aminopenicillansyra
SE435291B (sv) Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
NO142121C (no) Fremgangsmaate til fremstilling av perpropionsyreopploesoninger
SE428689B (sv) Forfarande for framstellning av aroyl-fenylnaftalenforeningar
SE427184B (sv) Forfarande for framstellning av 7-aminocefalosporansyraderivat
SE414927B (sv) Forfarande for framstellning av 1-metyl-2-(fenyloximetyl)-5-nitroimidazoler

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7610722-6

Effective date: 19880622

Format of ref document f/p: F